NP / PA
Avila, Stephanie
Avila, Stephanie was paid $1.08M by Medicaid between May 2018 and Dec 2024, across 42 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 15% of everything it billed.
33Billing provider infoAVILA, STEPHANIE
PROVIDENCE, RI 02905
PROVIDENCE, RI 02905
33aNPI1184643363assigned 07/19/2006
33bProvider typeNurse Practitioner
28Total paid$1.08M
24GClaims17,031
24DCodes billed42
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Rhode Island
Rank by total paid#2 of 110
Median peer was paid$14K
This provider vs. median78×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 409 | $18K | |
| 2019 | 246 | $11K | |
| 2020 | 1,876 | $120K | |
| 2021 | 3,728 | $222K | |
| 2022 | 2,842 | $147K | |
| 2023 | 4,966 | $386K | |
| 2024incomplete | 2,964 | $180K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 15% | 1,122 | 1,086 | $167K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 11% | 1,119 | 1,083 | $117K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.0% | 2,238 | 2,091 | $98K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 6.9% | 982 | 949 | $75K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 5.4% | 844 | 794 | $59K |
| 86780 | 4.8% | 963 | 931 | $52K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.6% | 1,149 | 1,094 | $49K |
| 86481 | 2.9% | 216 | 200 | $32K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.7% | 275 | 263 | $29K |
| 86803 | 2.6% | 213 | 199 | $28K | |
| 86787 | 2.3% | 221 | 204 | $25K | |
| 86850 | 2.3% | 303 | 285 | $25K |
30 more codes
| 86762 | 2.3% | 223 | $25K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 803 | $25K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2.2% | 432 | $24K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2.0% | 81 | $22K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.0% | 206 | $22K |
| 87340 | 1.9% | 221 | $21K | |
| 86900 | 1.8% | 303 | $20K | |
| 86901 | 1.8% | 303 | $20K | |
| 59426 | 1.8% | 28 | $19K | |
| 87150 | 1.3% | 140 | $14K | |
| 81001 | 1.3% | 185 | $14K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 118 | $10K |
| 59430 | <1% | 84 | $9K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 132 | $8K |
| 76830 | Ultrasound, transvaginal | <1% | 27 | $8K |
| 83020 | <1% | 43 | $8K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 28 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 544 | $8K |
| 81025 | <1% | 1,587 | $8K | |
| 82950 | <1% | 197 | $6K | |
| 83021 | <1% | 43 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 656 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 74 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 66 | $4K |
| S0612 | Annual gynecological examination, established patient | <1% | 61 | $4K |
| 82105 | <1% | 63 | $3K | |
| 87210 | <1% | 701 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $2K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $738.90 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 13 | $375.46 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.